Key Developments: China Cord Blood Corp (CO)

CO on New York Consolidated

2.80USD
24 May 2013
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.80
Open
$2.80
Day's High
$2.84
Day's Low
$2.79
Volume
63,520
Avg. Vol
80,971
52-wk High
$3.20
52-wk Low
$2.21

Search Stocks

Latest Key Developments (Source: Significant Developments)

China Cord Blood Corp Announces Completion Of Strategic Partnership With Cordlife Group Limited
Monday, 12 Nov 2012 06:00am EST 

China Cord Blood Corp announced the completion of the transaction with Cordlife Group Limited, a cord blood and tissue banking service provider listed on the Singapore Exchange Securities Trading Limited. The transaction was first announced on August 15, 2012. As a result of the transaction, CCBC now wholly owns the equity ownership of Guangzhou Municipality Tianhe Nuoya Bio-engineering Co. Ltd, the Company's operating arm in Guangdong province, and Cordlife acquired 7,314,015 ordinary shares of the Company, representing approximately 10% of the Company's issued and outstanding shares. For the purpose of fostering a close alliance and building partnership between CCBC and Cordlife, the Board of Directors of CCBC has appointed Mr. Jeremy Yee as a non-executive independent director, effective from November 12, 2012.  Full Article

Golden Meditech Holdings Limited To Increase Stake In China Cord Blood Corporation To 39.5%
Thursday, 23 Jun 2011 06:00pm EDT 

Golden Meditech Holdings Limited announced that the Group has accumulated 754,791 ordinary shares in its NYSE-listed affiliate, China Cord Blood Corporation from the open market between December 2010 and March 2011. As a result of which the Group now owns 39.5% of the issued share capital of CCBC.  Full Article

  • Previous
  • Next

China Cord Blood Corp News

» More CO News

Earnings vs. Estimates

» More Financials
Search Stocks